Companies / Kura Oncology, Inc. / Activity
Activity — Kura Oncology, Inc.
16 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Powl Brian T. Executive | Sell | Common Stock | $41.0K | -5K -2.55% | 184,847 0.21% of shares | low |
| Jan 27, 2026 | Bair Teresa Brophy Executive | Sell | Common Stock | $40.4K | -5K -2.06% | 226,931 0.26% of shares | low |
| Jan 27, 2026 | Bair Teresa Brophy Executive | Sell | Common Stock | $34.7K | -4K -1.72% | 234,043 0.26% of shares | low |
| Jan 27, 2026 | Leoni Mollie Executive | Sell | Common Stock | $30.9K | -4K -1.33% | 271,799 0.31% of shares | low |
| Jan 27, 2026 | Bair Teresa Brophy Executive | Sell | Common Stock | $19.8K | -2K -1.00% | 231,708 0.26% of shares | low |
| Jan 27, 2026 | Leoni Mollie Executive | Sell | Common Stock | $18.9K | -2K -0.82% | 269,566 0.30% of shares | low |
| Jan 27, 2026 | Doyle Thomas James Executive | Sell | Common Stock | $18.8K | -2K -1.50% | 146,048 0.16% of shares | low |
| Jan 27, 2026 | Doyle Thomas James Executive | Sell | Common Stock | $18.8K | -2K -1.46% | 150,083 0.17% of shares | low |
| Jan 27, 2026 | Ford Kathleen Executive | Sell | Common Stock | $15.3K | -2K -1.17% | 153,560 0.17% of shares | low |
| Jan 27, 2026 | Powl Brian T. Executive | Sell | Common Stock | $13.3K | -2K -0.85% | 183,275 0.21% of shares | low |
| Jan 27, 2026 | Leoni Mollie Executive | Sell | Common Stock | $11.3K | -1K -0.50% | 267,274 0.30% of shares | low |
| Jan 27, 2026 | Burrows Francis Executive | Sell | Common Stock | $11.1K | -1K -3.89% | 32,424 0.04% of shares | low |
| Jan 27, 2026 | Doyle Thomas James Executive | Sell | Common Stock | $9.4K | -1K -0.74% | 148,969 0.17% of shares | low |
| Jan 27, 2026 | Leoni Mollie Executive | Sell | Common Stock | $8.0K | -951 -0.35% | 268,615 0.30% of shares | low |
| Jan 27, 2026 | Doyle Thomas James Executive | Sell | Common Stock | $7.5K | -881 -0.60% | 145,167 0.16% of shares | low |
| Jan 27, 2026 | Doyle Thomas James Executive | Sell | Common Stock | $5.9K | -695 -0.47% | 148,274 0.17% of shares | low |